BackChina Dasheng Biotechnology Company Overview
China Dasheng Biotechnology Company

China Dasheng Biotechnology Company Return on Equity

China Dasheng Biotechnology Company (CDBT) has a ROE of 163.89%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

163.89%

Return on Equity

163.89%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

China Dasheng Biotechnology Company (CDBT) FAQ

China Dasheng Biotechnology Company's return on equity stands at 163.89%. That is above the sector sector average of 11.3%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

China Dasheng Biotechnology Company sits higher the its sector benchmark (11.3%) with a ROE of 163.89%. That is roughly 1350.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 163.89% for China Dasheng Biotechnology Company means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how China Dasheng Biotechnology Company's ROE evolved across reporting periods, while the comparison chart places CDBT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers